Article

WCWL Rheumatology Priority Referral Score Reliability and Validity Testing

Conference|American College of Rheumatology

Avril Fitzgerald from University of Calgary, Calgary, AB, discussed the results from her study and how the primary care physicians and rheumatologists are perceiving the new scoring method.

Avril Fitzgerald from University of Calgary, Calgary, AB, discussed the results from her study and how the primary care physicians and rheumatologists are perceiving the new scoring method.

MP3 DOWNLOAD: 2009ACR_Fitzgerald.mp3

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Malin Fromme, MD | Credit: RWTH Aachen
Pavel Strnad, MD | Credit: AASLD
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Gideon Hirschfield, FRCP, PhD | Credit: UHN Foundation
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
Related Content
PEGylated Uricase Well-Tolerated, Demonstrates Dose-Dependent Urate-Lowering
November 28th 2024

PEGylated Uricase Well-Tolerated, Demonstrates Dose-Dependent Urate-Lowering

Victoria Johnson
Kidney Compass default thumbnail with podcast logo and headshots of hosts Brendon Neuen and Shikha Wadhwani.
October 27th 2024

Kidney Compass: Semaglutide for Nondiabetic Kidney Disease, with Hiddo Heerspink, PhD, PharmD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Zahi Touma, MD, PhD, director, Toronto Lupus Program and Associate Professor of medicine, department of medicine, division of rheumatology, Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto
November 27th 2024

Anifrolumab Delayed Onset of Organ Damage in Patients With SLE

Victoria Johnson
Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024
October 27th 2024

Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Urate-Lowering Therapy Remains Tolerable in Patients with Gout, CKD | Image Credit: ResearchGate
November 25th 2024

Urate-Lowering Therapy Remains Tolerable in Patients with Gout, CKD

Connor Iapoce
Strict Disease Control Criteria Linked to Increased Work Productivity for Patients with PsA
November 25th 2024

Strict Disease Control Criteria Linked to Increased Work Productivity for Patients with PsA

Tim Smith
© 2024 MJH Life Sciences

All rights reserved.